Penikila v. Sergeant's Pet Care Products, LLC

Background

Ramona Penikila alleged that Sergeant's Pet Care Products, LLC’s flea medicine irritated her dog’s skin and caused serious fur loss. She challenged the product’s statement that it was “safe for use around children and pets,” alleging that she relied on that statement, would not have bought or used the product had she known it was unsafe, and asserted claims including unfair competition, unjust enrichment, and breach of express and implied warranties. The opinion addresses the defendant’s motion to dismiss.

Standing

The court held that Penikila had standing, meaning she alleged a concrete injury fairly traceable to the defendant’s conduct that the court could remedy. The court said that possible choice-of-law issues concerning class claims did not affect the standing inquiry.

Personal jurisdiction and proposed class claims

The court denied the defendant’s attempt to dismiss claims of proposed out-of-state class members for lack of personal jurisdiction under Bristol-Myers Squibb Co. v. Superior Court. Before a class is certified, unnamed class members and their claims are not actually before the court as parties or asserted claims. The court therefore said those claims could not be dismissed at that stage.

The court stated that the proper procedure for arguing that a nationwide class could never be certified because of personal-jurisdiction problems would be a motion to strike the nationwide class allegations. It permitted the defendant to file that separate motion no later than 14 days after the ruling, scheduled a hearing for April 23, 2020, and stayed discovery concerning out-of-state proposed class members until then. The court also rejected the defendant’s stated position that it lacked specific jurisdiction over Penikila’s own claims, because she bought and used the product in California, and said the defendant could not file a renewed motion to dismiss on that basis.

Failure to state a claim

The court rejected the argument that federal pesticide regulations protected the product’s safety statement. Although the product’s essential oils were subject to less restrictive rules for “minimum risk pesticides,” those rules still prohibited false and misleading labeling statements. Penikila’s allegation that the medicine poisoned pets, if true, would make the safety statement misleading or false.

The court held that Penikila adequately pleaded justifiable reliance because she alleged that the statement led her to believe the medicine was safe for her dog and that she would not have purchased or used it otherwise. The defendant’s suspicions about her motives did not defeat those allegations at the motion-to-dismiss stage.

The court denied dismissal of the unjust-enrichment claim. It also denied dismissal of the express-warranty claim, holding that a purchaser who relies on a manufacturer’s misleading label or advertising may sue without proving a direct contractual relationship with the manufacturer, and that the safety statement was specific enough in the context of flea medicine to constitute an express warranty.

The court denied dismissal of the implied-warranty claim without prejudice to raising the issue again at the summary-judgment stage. If the issue was briefed again, the parties were directed to address the possible pesticide exception and the possible exception for third-party beneficiaries.

Disposition

Judge Vince Chhabria denied the defendant’s motion to dismiss. The order did not decide whether a nationwide class should be certified; it allowed the defendant to pursue that issue through a separate motion to strike.